My Blue Dots

CAMBRIDGE, Mass.–(BUSINESS WIRE)–City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced that it has entered into a strategic collaboration with global eye health leader Bausch + Lomb focused on the development of a novel therapy for the treatment of retinal diseases including geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD) that causes irreversible vision loss. Through

DALLAS–(BUSINESS WIRE)– #fortworth–Leading Robotics Integrator, RobotLAB, Expands Best-In-Class Robotics Business Solutions to San Antonio

CARLSBAD, Calif.–(BUSINESS WIRE)–Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients is associated with lower healthcare resource utilization (HCRU) and a significant reduction in associated costs., including a 61% overall reduction in outpatient costs.1 This independently analyzed real-world study conducted by research firm OM1 evaluated medical

NEW YORK & PITTSBURGH–(BUSINESS WIRE)–TruFood Manufacturing (“TruFood”) and Bar Bakers, LLC (“Bar Bakers”) are proud to unveil their new unified brand identity: Tandem Foods, a premier contract manufacturer specializing in better-for-you snacks. The milestone builds on the successful Spring 2024 merger of the two companies, marking the evolution of two trusted brands, creating the industry leader in the nutrition bar space. The enterprise is unified by its dedication to driving customer growt

SAN DIEGO–(BUSINESS WIRE)– #biobam–BioBam, a leading bioinformatics solutions provider, proudly presents OmicsBox Version 3.4 at the San Diego Plant and Animal Genome Conference (PAG 32). This latest release introduces a range of enhancements designed to address the evolving needs of modern genomics and transcriptomics research. A key highlight of OmicsBox 3.4 is the integration of CellKB, a robust cell-type prediction tool for single-cell RNA sequencing (scRNA-Seq) analysis. CellKB streamlines scRNA-

SEATTLE–(BUSINESS WIRE)–Cyrus Biotech today announced that its protease CYR212 has been selected as its clinical candidate for chronic IgG-driven autoimmune diseases.

SEATTLE–(BUSINESS WIRE)–A Parse Biosciences, líder em soluções acessíveis e escalonáveis para sequenciamento de células individuais, anunciou hoje uma expansão significativa na funcionalidade do Evercode™ WT Mega Kit. Agora, os pesquisadores podem analisar até 384 amostras e 1 milhão de células em um único experimento, abrindo novas possibilidades para estudos de alto rendimento. Embora as tecnologias de células individuais tenham avançado constantemente, muitas ainda enfrentam limitações ao